Dr. Daniel Lewis Spitz, MD

Dr. Spitz practices at Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare.

Dr. Spitz's NPI, 1134125214, was assigned on June 23, 2005. Dr. Spitz graduated from Medical University of South Carolina (MUSC) in 1980. Dr. Spitz holds Florida license ME45443.

Dr. Spitz's primary practice is Good Samaritan Medical Center, at 1309 N Flagler Dr, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 655-5511.

Dr. Spitz's primary practice is Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare. Dr. Spitz is also affiliated with Jupiter Medical Center. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Spitz to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spitz practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Spitz's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Spitz is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Spitz's licenses on file in 15 states: Florida, New York, Illinois, Michigan, Ohio, Utah, Arizona, California, Georgia, Idaho, Indiana, Kentucky, Maryland, Missouri and Mississippi.

Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Spitz treats.

CMS data shows 147,372 Medicare services from Dr. Spitz across 53 procedure codes in 2024, for 872 Medicare patients. Medicare paid $2,285,813 for them.

CMS counts 872 Medicare patients who saw Dr. Spitz in 2024. The largest group is 75 to 84, with 359 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spitz's median patient age at 65, with 64% women.

In 2024, Dr. Spitz wrote 1,472 Medicare Part D claims for 293 patients. 72% of them were for generic drugs. CMS names the drug for 1,125 of them, across 41 drugs with 11 or more claims each, at $2,504,824 in total drug cost. In 2023, CMS named 1,014 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Spitz for performance year 2024, reported as part of a group. Dr. Spitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Spitz, published from 2013 to 2024. Dr. Spitz's most frequent co-authors are Erika P. Hamilton, MD, Todd Michael Bauer, MD and J Thaddeus Beck, FACP, MD.

Dmand AI links Dr. Spitz to 8 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases, Carcinoma, Ovarian Epithelial and Ovarian Neoplasms. AbbVie sponsors the most, 2. Open Payments lists research payments to Dr. Spitz that name 1 trial.

CMS Open Payments shows 2,065 general payments to Dr. Spitz from 104 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Sanofi and Genzyme US Companies paid the most, $12,251. It also lists 36 research payments totaling $35,349 from 2016 to 2023, naming 1 clinical trial.

Dr. Spitz graduated from Medical University of South Carolina (MUSC) in 1980.

Dr. Spitz is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.